Amphastar Pharmaceuticals Inc.
AMPH | NASDAQ
$24.75
+$0.27 (+1.10%)
Sep 22, 2026, 12:23 PM ET · Market open
Market Data
Market Cap $1.08B
Enterprise Value $1.48B
Beta 0.92
Average Volume 559.31K
Shares Outstanding (Diluted) 44.23M
Shares Change YoY -8.11%
Institutional Ownership 71.37%
Exchange NASDAQ
ISIN US03209R1032
Price Performance
Price Change 1M 14.8%
Price Change 3M 25.4%
Price Change 6M 25.1%
Price Change YTD -7.5%
Price Change 1Y -12.2%
Price Change 3Y -46.2%
Price Change 5Y 30.8%
1M CAGR (ann.) 17.8%
1Y CAGR (ann.) -10.8%
5Y CAGR (ann.) 5.8%
All-Time CAGR 8.8%
Valuation
PE Ratio 14.49
Forward PE 7.49
PEG Ratio -0.37
Forward PEG 1.98
PS Ratio 1.48
Forward PS 1.40
PB Ratio 1.41
P/FCF Ratio 5.64
P/Adj. FCF Ratio 7.05
P/OCF Ratio 5.79
EV/Sales 2.02
EV/EBIT 11.53
EV/EBITDA 8.46
EV/FCF 7.73
Earnings Yield 6.9%
FCF Yield 17.7%
Adj. FCF Yield 14.2%
Financial Health
Net Debt $321.93M
Total Debt $688.32M
Cash & Short-Term Investments $290.12M
Total Assets $1.74B
Current Ratio 2.40
Quick Ratio 1.71
Debt / Equity Ratio 0.90
Debt / EBITDA 3.94
Debt / FCF 3.60
OCF / Debt 0.34
Interest Coverage 4.37
Altman Z-Score 2.14
Piotroski F-Score 5
Margins & Profitability
Gross Profit Margin 47.7%
Operating Profit Margin 15.7%
EBITDA Margin 23.9%
Net Profit Margin 10.8%
FCF Margin 26.2%
Adj. FCF Margin 21.0%
SBC / Revenue 4.0%
SBC Impact (per share) -20.0%
Returns
Return on Assets 4.5%
Return on Equity 10.1%
Return on Invested Capital 5.9%
Return on Capital Employed 7.7%
Return on Tangible Assets 6.7%
Historical Growth (CAGR)
Revenue CAGR 3Y 10.5%
Revenue CAGR 5Y 13.7%
Revenue CAGR 10Y 10.5%
EPS CAGR 3Y -4.7%
EPS CAGR 5Y 51.8%
EPS CAGR 10Y 18.9%
FCF CAGR 3Y 23.9%
FCF CAGR 5Y 29.6%
FCF CAGR 10Y 31.6%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 12
EPS Growth Next 3Y 23.3%
Revenue Growth Next 3Y 6.1%
Earnings Date Nov 4, 2026
EPS Estimate (next Q) $0.86
EPS Growth Est (next Q) -7.1%
Revenue Est (next Q) $197.85M
Revenue Growth Est (next Q) 3.1%
Fair Value Estimates
Graham Number $25.87
Graham Upside 5.7%
Lynch Fair Value $42.25
Lynch Upside 72.6%
Price Target $21.25
Price Target Upside -13.2%
Cash Flow
Operating Cash Flow $232.45M
Free Cash Flow $191.23M
Adj. Free Cash Flow $153.09M
FCF Per Share $3.50
OCF Per Share $4.23
OCF/S Ratio 25.3%
Income Statement
Revenue $730.02M
Gross Profit $348.11M
Operating Income $114.29M
EBITDA $174.76M
Net Income $78.55M
EPS (Diluted) $1.69
Revenue / Employee $369.44K
Profit / Employee $39.75K
Employees 1,976
Add to Watchlist
Select watchlists to add or remove AMPH